Stock Market Update

22-Dec-25 12:35 ET
Moderna outperforms despite vaccine headlines
Dow +258.50 at 48393.18, Nasdaq +129.49 at 23437.14, S&P +40.70 at 6875.19

[BRIEFING.COM] The S&P 500 (+0.6%), Nasdaq Composite (+0.6%), and DJIA (+0.5%) continue to hover at session highs. 

The health care sector (+0.4%) is the best performing of the defensive sectors today, as the utilities sector is flat and the consumer staples sector (-0.3%) lags. 

The New York Times reported that Department of Health and Human Services Secretary Robert F. Kennedy Jr. is expected to announce next year a new immunization schedule for children that matches Denmark, which will result in fewer vaccinations. Despite the headline, Moderna (MRNA 35.68, +1.88, +5.56%) is one of the top-performing S&P 500 names today. The stock has been on a tear as of recent, gaining 37% since the start of December. 

Shares rose last week after The Hill reported the company will receive $54.3 million in funding for research into a potential bird flu vaccine from a global vaccine partnership fund. 

Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.